Financials
- Market Capitalization 433.78 M
- Employee 35
- Founded 1996
- CEO N/A
- Website www.fennecpharma.com
- Headquarter British Columbia, Canada
- FIGI BBG000DTH814
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-22.65
Relación precio/flujo de caja
4.93
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3056 | GALT Galectin Therapeutics Inc. - Common Stock | 4.07 USD | -1.69% | +9.41% | +18.66% | -3.10% | 410.46 M USD | ||
| 3060 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.06 USD | -4.02% | 0.00% | +3.31% | +36.70% | 402.54 M USD | ||
| 3071 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.80 USD | -3.81% | -2.24% | +9.34% | -0.21% | 393.82 M USD | ||
| 3073 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.57 USD | -1.67% | +2.42% | +8.04% | +56.16% | 395.23 M USD |